Lower Urinary Tract Symptoms Clinical Trial
Official title:
ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE)
This registry study enables us to collect data on the treatment of LUTS using prostate artery
embolisation (PAE), and other surgical methods to answer the following questions posed by
NICE in 2013:
- Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?
- How does PAE compare with conventional surgical treatments? This will primarily be a
surgical procedure called transurethral resection of the prostate (TURP) (see below).
- Which patients would most benefit from PAE over the other treatment options?
This is a study protocol for the UK ROPE Register for Lower Urinary Tract Symptoms (LUTS).
This register enables us to collect data on the treatment of LUTS using prostate artery
embolisation (PAE), and other surgical methods to answer the following questions posed by
NICE in 2013:
- Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?
- How does PAE compare with conventional surgical treatments? This will primarily be a
surgical procedure called transurethral resection of the prostate (TURP) (see below).
- Which patients would most benefit from PAE over the other treatment options? This study
involves populating the UK ROPE Register with data from patients who have undergone
prostate artery embolisation (PAE) and the current standard treatment in the UK,
transurethral resection of the prostate (TURP). All consecutive patients receiving PAE
in UK sites taking part in this study over the course of 12 months (from the date that
the first patient is enrolled) will be invited to join the UK ROPE register. At least
150 PAE patients will be enrolled into this study, and a comparable number of TURP
patients (at least 150 patients also) from a maximum of 18 sites in the UK. It is
anticipated that each site will enrol between 10 and 30 PAE patients in 12 months.
Enrolment will only continue past 12 months until 150 PAE patients have been added to
the register.
NICE has suggested keeping a registry or database of patients who have undergone this
procedure in the UK. so that we can find out more about how safe and effective it is for
patients and how it compares to the other established treatments available such as surgery.
The UK ROPE Register will be owned and hosted by the British Society of Interventional
Radiologists (BSIR) and the British Association of Urological Surgeons (BAUS). The register
will be built by Dendrite, a commercial company that specialise in making medical registers
and databases. Cedar, a consortium of Cardiff & Vale UHB and Cardiff University and an
External Assessment Centre (EAC) to NICE, was commissioned to facilitate the registry
research. Cedar's role is to work with the steering group (consisting of BSIR, BAUS, and NICE
representatives) to help build the ROPE Register and ensure that the right data points are
collected to answer research questions for NICE. Cedar will also perform the data analysis
from the ROPE Register and will publish the results in a peer-reviewed scientific journal.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
Enrolling by invitation |
NCT06317116 -
Examining the Relationship Between Core Muscles and Bladder Issues in Children
|
||
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Recruiting |
NCT05814614 -
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation
|
N/A | |
Recruiting |
NCT04288427 -
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
|
N/A | |
Not yet recruiting |
NCT06452927 -
EEP in Patients With Urodynamically Proven DU/DA
|
N/A | |
Completed |
NCT02330107 -
Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men
|
N/A | |
Completed |
NCT03339609 -
Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children
|
N/A | |
Terminated |
NCT02003742 -
Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT01078545 -
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
|
N/A | |
Completed |
NCT02074644 -
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
|
N/A | |
Recruiting |
NCT03802851 -
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT05415748 -
Deprescribing Tamsulosin in Older Men
|
Phase 4 | |
Recruiting |
NCT05702294 -
Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .
|
N/A | |
Enrolling by invitation |
NCT05537272 -
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
|
Phase 4 | |
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Completed |
NCT04104100 -
Prevalence and Risk Factor of NP in Women With LUTS
|
||
Completed |
NCT04190641 -
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
|
N/A |